Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 23, 2025
Remote Monitoring and Control Provider Acorn Approved for Listing on Nasdaq Capital Market
GlobeNewswire
·
July 23, 2025
WILMINGTON, Del., July 23, 2025 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for backup power generators, gas pipelines and air compressors, today announced that its common stock has been …
Volatus Aerospace Launches Condor XL Heavy-Lift Drone Program
GlobeNewswire
·
July 23, 2025
TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB), a Canadian leader in aerial intelligence and cargo solutions, is pleased to announce the launch of its Condor XL heavy-lift drone program. Drawing …
Volatus Aerospace lance le programme de drones de transport lourd Condor XL
GlobeNewswire
·
July 23, 2025
TORONTO, 23 juill. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : ABB), un chef de file canadien en matière de renseignement aérien et de solutions de fret, est heureux d'annoncer le lancement de son programme de …
Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
GlobeNewswire
·
July 23, 2025
DUBLIN and BRIDGEWATER, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President …
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT
GlobeNewswire
·
July 23, 2025
HOUSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
GlobeNewswire
·
July 23, 2025
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously published estimates1 (3.9 per 100,000), which equates to …
Sky Quarry's Nevada-Based Refinery Launches Crowdfunding Campaign
GlobeNewswire
·
July 23, 2025
WOODS CROSS, Utah, July 23, 2025 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an integrated energy company focused on sustainable resource recovery, is pleased to announce the launch of a crowdfunding offering by its …
NextGen Digital Platforms Inc. Appoints Mahyar Akhbari to the Advisor Board
GlobeNewswire
·
July 23, 2025
Vancouver, B.C., July 23, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased …
Bio Usawa Biotechnology and ServareGMP Form Strategic Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa
GlobeNewswire
·
July 23, 2025
KIGALI, Rwanda and SAN FRANCISCO and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa) and ServareGMP (Servare) today announced a strategic partnership to establish advanced monoclonal antibody manufacturing capabilities …
BILT earns cybersecurity certification to support enterprise & government clients
GlobeNewswire
·
July 23, 2025
GRAPEVINE, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- BILT Incorporated, creators of the 3D Intelligent Instructions® platform, announced it has achieved ISO/IEC 27001:2022 certification, the globally recognized standard for information security management …
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
GlobeNewswire
·
July 23, 2025
- XIPERE Now Approved for Use in Multiple Global Markets - - Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector® - ALPHARETTA, Ga., July 23, 2025 (GLOBE …
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. …
Rogers Communications Declares 50 Cents per Share Quarterly Dividend
GlobeNewswire
·
July 23, 2025
TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“Rogers”) announced that a quarterly dividend totaling 50 cents per share (the “Quarterly Dividend”) has been declared on each of its outstanding …
Rogers Communications Reports Second Quarter 2025 Results
GlobeNewswire
·
July 23, 2025
Rogers delivers strong results and completion of transformational investments in the second quarter Reports growth in revenue and adjusted EBITDA in Wireless, Cable, and Media and delivers strong free cash flow Significantly accelerated deleveraging with …
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today …
FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
GlobeNewswire
·
July 23, 2025
FRIENDSWOOD, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its DecisionDx-Melanoma test has been granted Breakthrough …
Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI
GlobeNewswire
·
July 23, 2025
TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intracoronary imaging technologies, is pleased to highlight the recent publication in The American Journal of Cardiology titled “Regional …
La Production de Silice Pyrogénée à L’échelle Pilote d’HPQ Approche la Viabilité Commerciale
GlobeNewswire
·
July 23, 2025
MONTRÉAL, 23 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique axée sur l’innovation dans le développement de matériaux avancés et de procédés critiques, a le …
HPQ’s Pilot-Scale Fumed Silica Production Nears Commercial Viability
GlobeNewswire
·
July 23, 2025
MONTREAL, July 23, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to update shareholders on …